- HS-20089£¨ºÏ×÷·½´úÂëGSK5733584£©ÊǰÐÏòB7-H4µÄ¿¹ÌåµÏÍþ¹ú¼ÊÎïżÁªÎADC£©£¬ÔÚδɸѡB7-H4±í´ïµÄÇé¿öÏ£¬ÔÚ¾¶àÏßÖÎÁÆÊ§°ÜµÄ²¬Ä͵ÏÍþ¹ú¼ÊÂѳ²°©£¨PROC£©»¼ÕßÖÐÕ¹ÏÖ³öÁîÈ˹ÄÎèµÄÁÆÐ§¡£ÔÚ4.8mg/kgµÄ¼ÁÁ¿Ë®Æ½Ï£¬HS-20089ÔÚPROCÊÜÊÔÕßÖÐÈ·ÈϵĿ͹ۻº½âÂÊ£¨ORR£©Îª48.5%£¬»º½â³ÖÐøÊ±¼ä£¨DoR£©´ï6.8¸öÔ£»ÖÐλÎÞ½øÕ¹Éú´æÆÚ£¨mPFS£©Îª6.4¸öÔ£¬ÖÐλ×ÜÉú´æÆÚ£¨mOS£©Îª14.6¸öÔ¡£
- HS-20089µÄ°²È«ÐԿɿأ¬Î´·¢ÏÖÐµİ²È«ÐÔÐźš£
- ÉÏÊöÁÙ´²Ñо¿½á¹ûÖ§³Ö¸ÃµÏÍþ¹ú¼ÊÎïÔÚPROC»¼ÕßÖеĽøÒ»²½¿ª·¢£¬Ä¿Ç°Ïà¹ØµÄ¢óÆÚÑо¿£¨NCT06855069)ÕýÔÚ½øÐÐÖС£
¾ßÌåÐÅÏ¢ÈçÏ£º

±¾Ñо¿ÎªÒ»Ïî¶àÖÐÐÄ¡¢¿ª·Å±êÇ©¡¢IIÆÚÁÙ´²ÊÔÑ飬ּÔÚÆÀ¹ÀHS-20089×¢ÉäÒºÔÚ¸´·¢ÐÔ»ò×ªÒÆÐÔÂѳ²°©¼°×Ó¹¬ÄÚĤ°©»¼ÕßÖеÄÁÆÐ§¡¢°²È«ÐÔ¡¢µÏÍþ¹ú¼Ê´ú¶¯Á¦Ñ§ÌØÕ÷¼°ÃâÒßÔÐÔ¡£·ûºÏÌõ¼þµÄ»¼Õß±»½«½ÓÊÜÿ3ÖÜÒ»´Î¡¢¼ÁÁ¿Îª4.8 mg/kgµÄHS-20089×¢ÉäÖÎÁÆ¡£Ñо¿Î´¸ù¾ÝB7H4±í´ïˮƽ¶Ô½øÐл¼Õßɸѡ£¬µ«ÊÕ¼¯ÁË»¼ÕßµÄ×éÖ¯Ñù±¾ÒԻعËÐÔ¼ì²âB7H4µÄ±í´ïˮƽ¡£Ö÷ÒªÖÕµãΪÑо¿Õ߸ù¾ÝRECIST v1.1±ê×¼ÆÀ¹ÀµÄ¿Í¹Û»º½âÂÊ£¨ORR£©¡£±¾´Î±¨¸æÁ˶ÓÁÐ1µÄ½á¹û£¬Êý¾Ý½ØÖ¹ÈÕÆÚΪ2025Äê6ÔÂ20ÈÕ¡£
ÒÔÉÏHS-20089 Ñо¿½á¹û½«ÓÚ2025Äê¹ú¼Ê¸¾¿Æ°©Ö¢Ð»áÈ«ÇòÄê»á£¨IGCS 2025£©ÉÏÒÔ¿ÚÍ·±¨¸æµÄÐÎʽÔÙ·¢±í£¬¸Ã»áÒ齫ÔÚ2025 Äê 11 Ô 5-7 ÈÕÔÚÄÏ·Ç¿ªÆÕ¶ØÊÀ¼Í³Ç»áÒéÖÐÐľÙÐС£
¹ØÓÚHS-20089
HS-20089ÊÇÓɵÏÍþÖÆµÏÍþ¹ú¼Ê×ÔÖ÷Ñз¢µÄB7-H4°ÐÏòADC¡£½ØÖÁĿǰ£¬HS-20089ÓÃÓÚÖÎÁÆÂѳ²°©ÊÊÓ¦Ö¢ÒÑÔÚÖйú½øÈëIIIÆÚÁÙ´²Ñо¿½×¶Î£¬ÁíÓÐÓÃÓÚÖÎÁÆ×Ó¹¬ÄÚĤ°©¼°ÆäËûʵÌåÁöµÄPoC¸ÅÄîÑéÖ¤ÁÙ´²Ñо¿ÕýÔÚ½øÐС£
2023Äê10Ô£¬µÏÍþÖÆµÏÍþ¹ú¼ÊÊÚÓè¸ðÀ¼ËØÊ·¿Ë¿ª·¢¡¢Éú²ú¼°ÉÌÒµ»¯HS-20089È«Çò¶ÀÕ¼Ðí¿ÉȨÀû£¨²»º¬Öйú´ó½¡¢Ïã¸Û¡¢°ÄÃż°Ì¨ÍåµØÇø£©¡£GSK ÕýÔÚͨ¹ýÈ«Çò¿ª·¢¼Æ»®Íƽø GSK5733584£¬Ä¿Ç°ÕýÔÚÈ«Çò·¶Î§ÄÚ½øÐÐµÄ I ÆÚÁÙ´²ÊÔÑ飬°üÀ¨ BEHOLD-1£¨NCT06431594£©ºÍ BEHOLD-2£¨NCT06796907£©Ñо¿¡£
2025Äê5Ô£¬HS-20089»ñNMPAÅú×¼ÄÉÈëÍ»ÆÆÐÔÖÎÁƵÏÍþ¹ú¼ÊÎÄⶨÊÊӦ֢ΪÓÃÓÚº¬²¬Ä͵ÏÍþ¹ú¼Ê¸´·¢ÉÏÆ¤ÐÔÂѳ²°©¡¢ÊäÂѹܰ©»òÔ·¢ÐÔ¸¹Ä¤°©»¼Õß¡£
¹ØÓÚÂѳ²°©
Âѳ²°©£¨OC£©ÊÇ×î³£¼ûµÄ¸¾¿Æ¶ñÐÔÖ×ÁöÖ®Ò»£¬2022Ä꣬ȫÇòÔ¼Õï¶Ï³ö324,603ÀýÂѳ²°©Ð²¡Àý£¬Ê¹Æä³ÉΪŮÐÔÖеڰ˴󳣼û¶ñÐÔÖ×Áö¡£¸ÃÄêÔ¼ÓÐ206,956ÀýÂѳ²°©ËÀÍö£¬Âѳ²°©³ÉΪŮÐÔ°©Ö¢Ïà¹ØËÀÍöµÄµÚ°Ë´óÔÒò¡£ÔÚÖйú£¬2022ÄêÂѳ²°©µÄ·¢²¡ÊýΪ61,060Àý£¬ËÀÍöÈËÊýΪ32,646Àý[1] ¡£
ÊÖÊõÁªºÏÒÔ²¬Îª»ù´¡µÄ»¯ÁÆÊÇĿǰÂѳ²°©µÄ±ê×¼ÖÎÁÆ·½Ê½£¬µ«¾ø´ó²¿·ÖÍíÆÚ»¼Õß»áÔÚ3ÄêÄÚ¸´·¢£¬²¢×îÖÕ»á¶Ô²¬À໯ÁƲúÉúÄ͵ÏÍþ¹ú¼ÊÐÔ£¬²¬Ä͵ÏÍþ¹ú¼Ê¸´·¢Âѳ²°©£¨PROC£©µÄÁÙ´²ÖÎÁÆÊֶκÍÁÆÐ§¾ùÊ®·ÖÓÐÏÞ¡£¸ù¾Ý½üÄêÀ´¿ªÕ¹µÄ¢óÆÚËæ»ú¶ÔÕÕÑо¿ÖеĶÔÕÕ×飨·Ç²¬µ¥µÏÍþ¹ú¼Ê»¯ÁÆ£©Êý¾ÝÏÔʾ£¬·Ç²¬µ¥µÏÍþ¹ú¼Ê»¯ÁÆÂѳ²°©µÄ¿Í¹Û»º½âÂÊ£¨ORR£©½ö4%~15.9%£¬ÖÐλÎÞ½øÕ¹Éú´æÆÚ£¨mPFS£©½ö3.4~3.98¸öÔ¡£¶ÔÓÚ½ÓÊܹý1ÖÁ2ÏßÖÎÁƵϼÕߣ¬·Ç²¬»¯ÁƽáºÏ±´·¥Öéµ¥¿¹µÄORRΪ27.3%£¬mPFSÑÓ³¤ÖÁ6.7¸öÔ£¬ÖÐλÉú´æÆÚ£¨mOS£©´ïµ½16.6¸öÔ¡£¾¡¹ÜPFSÏÔÖøÑÓ³¤£¬µ«OSÓë·Ç²¬»¯ÁÆÏà±ÈÎÞÃ÷ÏÔ»ñÒæ[2-6] ¡£Ä¿Ç°¸Ã¼²²¡ÈÔ´æÔÚ¾Þ´óδ±»Âú×ãµÄÁÙ´²ÐèÇ󣬨½´ýѰÕÒ¸üΪÓÐЧµÄÖÎÁÆ·½Ê½¡£
¹ØÓÚESMO
Å·ÖÞÖ×ÁöÄÚ¿ÆÑ§»á£¨ESMO£©Äê»áÊÇÈ«Çò×î¾ßÓ°ÏìÁ¦µÄÖ×Áöѧ»áÒéÖ®Ò»¡£±¾´Î´ó»á»ã¼¯ÁËÀ´×ÔÊÀ½ç¸÷µØµÄ¶¥¼âר¼Ò¡¢Ñо¿Ô±¡¢Ò½ÁƱ£½¡ÐÐÒµ´ú±í£¬¹²Í¬Ì½ÌÖÖ×ÁöѧÁìÓòµÄ×îнøÕ¹ºÍÇ°ÑØÑо¿£¬ÄÚÈݺ¸Ç´Ó»ù´¡Ñо¿µ½°©Ö¢ÃâÒßÖÎÁÆ£¬´ÓÖ×Áö»¤Àíµ½¹ÃÏ¢ÖÎÁÆ£¬´Óº±¼û°©Ö¢µ½µÏÍþ¹ú¼ÊÎïÅú×¼µÈ¡£
²Î¿¼ÎÄÏ×£º
[1]International Agency for Research on Cancer. (2024). Cancer TODAY: GLOBOCAN 2022 (version 1.1). Retrieved April 26, 2025, from Global Cancer Observatory
[2]Pujade-Lauraine E, Fujiwara K, Ledermann JA, et al. Lancet Oncol. Jul 2021;22(7):1034-1046.
[3] Gaillard S, Oaknin A, Ray-Coquard I, et al. Gynecol Oncol. Nov 2021;163(2):237-245.
[4] Hamanishi J, Takeshima N, Katsumata N, et al. J Clin Oncol. Nov 20 2021;39(33):3671-3681.
[5] Pujade-Lauraine E, Hilpert F, Weber B, et al.
[6] Moore KN, Angelergues A, Konecny GE, et al. N Engl J Med. Dec 7 2023;389(23):2162-2174.
¹ØÓÚµÏÍþÖÆµÏÍþ¹ú¼Ê
ÃâÔðÉùÃ÷
ǰհÐÔ˵Ã÷